[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"dysphagia\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:dysphagia":28},{"pageToken":4,"total":5,"offset":6,"count":7,"results":8},null,93,0,25,[9,45,58,87,128,157,191,215,241,269,297,326,359,380,403,426,450,479,509,529,552,577,598,623,656],{"id":10,"slug":11,"hasResults":12,"nctId":13,"briefTitle":14,"officialTitle":15,"acronym":4,"eligibilityCriteria":16,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":30,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100054223","the-esophageal-string-test-as-a-diagnostic-screening-tool-for-eosinophilic-esophagitis-among-africans-with-dysphagia-in-mali-and-the-united-states-100054223",false,"NCT07027826","The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States","Use of the Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States","* INCLUSION CRITERIA:\n\nIn order to be eligible to participate in this study, an individual must meet all of the following criteria:\n\n1. Able to provide informed consent.\n2. Aged 18 to 65 years.\n3. Born in the African continent or their parents were born in Africa,\n4. Exhibiting symptoms of dysphagia and\u002For prior history of food impaction.\n5. Undergoing clinically indicated endoscopy at the NIH Clinical Center (U.S.), Centre Hospitalier Universitaire Gabriel Tour(SqrRoot)(Copyright) (Mali), or other local clinics (Mali) and willing to provide research samples and data.\n\nEXCLUSION CRITERIA:\n\nAn individual who meets any of the following criteria will be excluded from participation in this study:\n\n1. Recent steroid use (systemic or swallowed\u002Ftopical corticosteroid) within 4 weeks prior to endoscopy.\n2. Recent use of dupilumab (Dupixent) within the last 6 months.\n3. Recent use of other biologic medications (within either 6 months or 5 half-lives, whichever is longer). Examples of biologic medications include:\n\n3a. mepolizumab (Nucala)\n\n3b. reslizumab (Cinqair, Cinqaero)\n\n3c. benralizumab (Fasenra)\n\n3d. cendakimab\n\n3e. tezepelumab (Tezspire)\n\n3f. barzolvolimab\n\n4\\. Individuals suffering from a bleeding diathesis (e.g., hemophilia, severe thrombocytopenia).\n\n5\\. Current use of anticoagulant medications.\n\n6\\. Pregnancy.\n\n7\\. Treatment with another investigational drug or other investigational intervention within 6 months or 5 half-lives whichever is longer.\n\n8\\. Individuals with a known history of any of the following:\n\n8a. eosinophilic esophagitis\n\n8b. esophageal stricture unable to be passed with an upper endoscope\n\n8c. esophageal cancer\n\n8d. esophageal motility disorder (e.g., achalasia)\n\n8e. esophageal varices\n\n8f. esophageal or gastric surgery including fundoplication\n\n8g. neurologic cause of dysphagia (e.g., stroke, Parkinson s disease, etc.)\n\n8h. allergy to gelatin\n\n8i. inability to swallow pills\n\n9\\. Any condition that, in the investigator s opinion, places the individual at undue risk by participating in the study.\n\nCo-enrollment guidelines: Co-enrollment in other trials is restricted, other than enrollment on observational studies. Consideration for co-enrollment in trials evaluating the use of a licensed medication will require the approval of the principal investigator in consultation with the medical monitor. Study staff should be notified of co-enrollment on any other protocol as it may require the approval of the principal investigator.","ALL","18 Years","65 Years",{"count":21,"type":22},70,"ESTIMATED","INTERVENTIONAL",[25],"NA","Background:\n\nEosinophilic esophagitis (EoE) is a disease that causes inflammation in the esophagus. The esophagus is the tube that moves food from the mouth to the stomach. Diagnosing EoE currently requires a specialized tool called an endoscope. The esophageal string test (EST) is another test; the EST collects fluid from the upper digestive tract. An EST is simpler and cheaper than an endoscopy. Researchers want to know if an EST can diagnose EoE.\n\nObjective:\n\nTo test if the EST can diagnose EoE in people who have trouble swallowing.\n\nEligibility:\n\nAdults aged 18 to 65 years with trouble swallowing. They must have been born in the African continent or their parents were born in Africa.\n\nDesign:\n\nParticipants will be screened. They will give blood, stool, urine, and skin swab samples. They will complete surveys about their medical history, diet, symptoms, and home environment. They will bring a sample of their drinking water for testing.\n\nParticipants will have an EST. They will swallow a pill capsule that contains a nylon string. One end of the string will be taped to their cheek. The string will unravel down the esophagus and into the stomach. It will be pulled out after 1 hour. Fluids that soaked into the string will be tested.\n\nAt a different visit, participants will have an endoscopic exam. An endoscope is a flexible tube that is inserted down the mouth; it can be used to take tissue samples from the esophagus, stomach, and small intestine.\n\nParticipants will have a final visit in person, online, or by phone. They will take a survey and talk about their test results.",[28,29],"Dysphagia","Eosinophilic Esophagitis",[29,28,31],"Esophageal string test","RECRUITING","2026-07-10",{"date":35,"type":36},"2026-07-13","ACTUAL",{"date":38,"type":22},"2026-07-16",{"date":40,"type":22},"2027-08-31",{"name":42,"class":43},"National Institute of Allergy and Infectious Diseases (NIAID)","NIH",3,{"id":46,"slug":4,"hasResults":12,"nctId":13,"briefTitle":14,"officialTitle":15,"acronym":4,"eligibilityCriteria":16,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":47,"targetDuration":4,"studyType":23,"phases":48,"briefSummary":26,"conditions":49,"keywords":50,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":54,"completionDateStruct":56,"leadSponsor":57,"locationsCount":44},"100595082",{"count":21,"type":22},[25],[28,29],[29,28,31],"2026-07-01",{"date":53,"type":36},"2026-07-02",{"date":55,"type":22},"2026-07-07",{"date":40,"type":22},{"name":42,"class":43},{"id":59,"slug":60,"hasResults":12,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":4,"eligibilityCriteria":64,"healthyVolunteers":65,"sex":17,"minAge":18,"maxAge":66,"enrollmentInfo":67,"targetDuration":4,"studyType":23,"phases":68,"briefSummary":69,"conditions":70,"keywords":71,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":86},"100629470","standardizing-swallow-pressure-measurements-100629470","NCT07475091","Standardizing Swallow Pressure Measurements","Pharyngeal High Resolution Manometry Standardization of Metrics","Inclusion Criteria:\n\n* without known swallowing disorders\n\nExclusion Criteria:\n\n* Known swallowing disorder\n* Allergy to topical anesthetic\n* Allergy to food relevant to study participation (e.g. lactose intolerance)\n* Inability to follow direction or remain calm during the experiment.",true,"99 Years",{"count":7,"type":22},[25],"This study aims to directly compare and contrast swallowing pressure and impedance measurements obtained from two high-resolution manometry (HRM) systems: the Laborie LMT Pharyngeal System and the Medtronic ManoScan ESO HRM System in healthy adult volunteers. The primary objective is to determine how differences in catheter diameter, sensor configuration, and acquisition platforms influence measurement outcomes. Twenty-five healthy adults will participate in a single, approximately 2-hour visit; the study will be open for one year for data collection and two years for data analysis.",[28],[72,73,74,75],"pharyngeal pressure events","swallowing","measurement","diagnosis","NOT_YET_RECRUITING","2026-06-30",{"date":51,"type":36},{"date":80,"type":22},"2026-07",{"date":82,"type":22},"2027-06",{"name":84,"class":85},"University of Wisconsin, Madison","OTHER",1,{"id":88,"slug":89,"hasResults":12,"nctId":90,"briefTitle":91,"officialTitle":92,"acronym":93,"eligibilityCriteria":94,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":95,"targetDuration":4,"studyType":23,"phases":97,"briefSummary":98,"conditions":99,"keywords":111,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":119,"lastUpdatePostDateStruct":120,"startDateStruct":122,"completionDateStruct":124,"leadSponsor":126,"locationsCount":86},"100557838","marginal-ulcer-healing-with-low-thermal-argon-plasma-endoscopic-treatment-100557838","NCT06543316","Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment","Accelerated Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment","AMULET","Inclusion Criteria:\n\n* Subjects aged 18 years and above, inclusive of both males and females.\n* Patients with a history of Roux-en-Y gastric bypass (RYGB) presenting symptoms indicative of marginal ulcers (MUs) such as abdominal pain, nausea, vomiting, gastrointestinal bleeding, or dysphagia.\n* Subjects must be scheduled for an EGD for the evaluation of these symptoms.\n* Marginal ulcers confirmed during the initial EGD.\n* Willingness to adhere to the SOC treatment, which includes PPIs.\n* Subjects able to tolerate repeated endoscopic procedures.\n* Capacity for providing informed consent and understanding of study requirements.\n* Willingness and ability to attend required follow-up assessments at 4 weeks (+\u002F- 1 week) and 8 weeks (+\u002F- 2 weeks).\n\nExclusion Criteria:\n\n* Inability to provide informed consent.\n* Unwillingness to undergo repeated endoscopies.\n* Inability or unwillingness to comply with the SOC.\n* Current use of systemic antibiotics.\n* Any condition deemed by the investigator to compromise the safety of undergoing an endoscopic procedure.\n* Pregnancy, lactation, or absence of reliable contraception in women of childbearing potential.\n* Current enrollment in another investigational trial with potential to interfere with this study's endpoint analyses.",{"count":96,"type":22},100,[25],"The objective of the study is to investigate the treatment of marginal ulcers with Low Thermal plasma in an endoscopic setting. By a treatment of the ulcerated areas with argon plasma with low power settings (\\~ 1 W) we hypothesize that the size of the ulcers will shrink, and the healing is accelerated compared to standard of care alone. Patients will benefit from this minimally invasive approach compared to a much more invasive surgical approach that comes with higher risks and hospital stay length time. From a societal and scientific perspective, this study aims to extend the well-documented clinical benefits of plasma technology - from external wound healing to internal ulcer treatment - within an endoscopic framework. The success of this study could pave the way for broader applications of LTP in the treatment of other endoscopically accessible conditions such as peptic ulcers, duodenal ulcers and esophageal ulcers. This advancement has the potential not only to improve patient outcomes through less invasive methods, but also to position LTP as a cornerstone in the future of gastroenterological wound management strategies.",[100,101,102,103,104,105,106,107,108,109,28,110],"Roux-en-y Anastomosis Site","Marginal Ulcer","Marginal Ulcer (Peptic) or Erosion","Ulcer","Ulcer, Gastric","Ulcer Gastrointestinal","Abdominal Pain","Nausea","Vomiting","GastroIntestinal Bleeding","Ulcer Gastrojejunal",[112,113,114,115,116,117,118],"Argon Plasma Coagulation","APC","Low-Thermal Argon Plasma Endoscopic Treatment","Endoscopy","RYGB","Roux-en-Y Gastric Bypass","Ulcer Healing","2026-06-23",{"date":121,"type":36},"2026-06-25",{"date":123,"type":36},"2025-03-04",{"date":125,"type":22},"2028-06",{"name":127,"class":85},"Christopher C. Thompson, MD, MSc",{"id":129,"slug":130,"hasResults":12,"nctId":131,"briefTitle":132,"officialTitle":133,"acronym":4,"eligibilityCriteria":134,"healthyVolunteers":12,"sex":17,"minAge":135,"maxAge":136,"enrollmentInfo":137,"targetDuration":4,"studyType":23,"phases":138,"briefSummary":139,"conditions":140,"keywords":143,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":148,"lastUpdatePostDateStruct":149,"startDateStruct":151,"completionDateStruct":153,"leadSponsor":155,"locationsCount":4},"100641065","efficacy-and-mechanism-of-yanjiu-needle-for-pharyngeal-dysphagia-based-on-semg-features-100641065","NCT07656025","Efficacy and Mechanism of 'Yanjiu Needle' for Pharyngeal Dysphagia Based on sEMG Features","Therapeutic Efficacy and Mechanistic Study of Yanjiu Acupuncture in Patients With Pharyngeal Dysphagia Based on Surface Electromyographic Features","Inclusion Criteria:\n\n* First onset of stroke with swallowing disorders lasting for 2 weeks to 6 months;\n* Stable vital signs, able to understand and execute physician instructions, and cooperate with treatment;\n* Age range: 40-75 years old, male or female not limited;\n* Functional Oral Intake Scale (FOIS) classification ≤ 4;\n* The patient's surgical site can receive acupuncture treatment;\n* Informed consent from patients or family members.\n\nExclusion Criteria:\n\n* Individuals with unstable vital signs who are unable to complete assessment and treatment;\n* Individuals with severe cognitive impairment, communication barriers, or other mental illnesses who are unable to cooperate with treatment;\n* Individuals with a history of oral, pharyngeal, and esophageal structural abnormalities, cricopharyngeal muscle stenosis, and cancer;\n* Confirmed by cranial CT\u002FMRI as a deceased with brainstem infarction\u002Fhemorrhage and extensive cerebral infarction;\n* Participants in other clinical trials;\n* Those who cannot accept surface electromyography examination; Pregnant and lactating women.","40 Years","75 Years",{"count":96,"type":22},[25],"Dysphagia is one of the most common and serious complications following stroke. It can easily lead to aspiration and aspiration pneumonia, reduce patients' quality of life, increase healthcare costs, and result in high mortality rates, making it a clinical issue that urgently needs to be addressed. Current mainstream therapies have limitations: neurostimulation targets a single pathway, while rehabilitation training offers only limited improvement in microcirculation and suffers from low patient compliance. Although acupuncture shows promise, it lacks high-quality randomized controlled evidence, and the specific acupuncture techniques lack standardized operational protocols, limiting their widespread adoption. In preliminary clinical practice, Chen Xiaokai, a renowned traditional Chinese medicine practitioner in Guangdong Province, developed the \"Nine Pharyngeal Acupoints\" (including Lianquan and Renying) based on the \"resolving knots\" theory. This approach can rapidly improve pharyngeal muscle tone and swallowing function. Basic research has confirmed that stimulation of these acupoints promotes pharyngeal circulation, activates the brainstem, and aids in the restoration of the swallowing reflex. This study aims to conduct a single-center, assessor-blinded, randomized, controlled, prospective superiority clinical trial. Using surface electromyography (EMG) as the core assessment tool, combined with swallowing videofluoroscopy and functional scales, the study will analyze the efficacy and neuro-muscular regulatory mechanisms of the \"Nine Pharyngeal Acupoints\" technique. The study is expected to clarify its therapeutic efficacy, establish standard operating procedures, and provide a basis for clinical implementation.",[141,28,142],"Acupuncture","Surface EMG",[144,28,145,141,146,147],"Stroke","Nine needles for swallowing","Clinical research","mechanism","2026-06-16",{"date":150,"type":36},"2026-06-18",{"date":152,"type":22},"2026-06-20",{"date":154,"type":22},"2028-12-20",{"name":156,"class":85},"The Third People's Hospital of Huizhou",{"id":158,"slug":159,"hasResults":12,"nctId":160,"briefTitle":161,"officialTitle":162,"acronym":4,"eligibilityCriteria":163,"healthyVolunteers":12,"sex":17,"minAge":164,"maxAge":4,"enrollmentInfo":165,"targetDuration":4,"studyType":23,"phases":167,"briefSummary":168,"conditions":169,"keywords":171,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":182,"lastUpdatePostDateStruct":183,"startDateStruct":185,"completionDateStruct":187,"leadSponsor":189,"locationsCount":86},"100641456","ai-enabled-mobile-app-for-safe-eating-in-older-adults-with-dysphagia-100641456","NCT07654088","AI-Enabled Mobile App for Safe Eating in Older Adults With Dysphagia","Efficacy of an AI-enabled Mobile Application for Safe Eating in Community-dwelling Older Adults With Dysphagia: a Randomized Controlled Trial","Inclusion Criteria:\n\n* Adults aged 60 years or above\n* Community-dwelling (living in a home or community setting)\n* Suspected or clinically identified oropharyngeal dysphagia\n* Currently consuming food or liquids orally at texture-modified levels\n* Able to provide informed consent, or with caregiver support if mild cognitive impairment is present\n* Access to a smartphone or tablet, either independently or with caregiver assistance\n* Willing and able to participate in study procedures and follow-up assessments\n\nExclusion Criteria:\n\n* Exclusive dependence on non-oral feeding (e.g., tube feeding)\n* Severe cognitive impairment or severe visual impairment that prevents meaningful participation\n* Medical conditions or circumstances that make participation unsafe\n* Life expectancy less than 6 months\n* Current participation in another dysphagia-related interventional study\n* Use of other digital tools specifically designed for food texture classification during the study period","60 Years",{"count":166,"type":22},332,[25],"Difficulty swallowing (called dysphagia) is common in older adults and can make eating and drinking unsafe. It may lead to serious problems such as choking, lung infections, poor nutrition, and reduced quality of life. One common way to reduce these risks is to modify food and drink textures (for example, making foods softer or liquids thicker). However, people often find it difficult to prepare food at the correct texture level in everyday life, especially at home, which may reduce the effectiveness of this approach.\n\nThis study aims to test whether a smartphone application powered by artificial intelligence (AI) can help older adults with swallowing difficulties eat more safely. The app allows users (or their caregivers) to take a photo of food or drinks, and the app then estimates the texture level and provides guidance to help ensure it is safe to swallow. It also gives simple prompts to double-check food texture when needed.\n\nIn this clinical trial, community-dwelling adults aged 60 years or above with swallowing difficulties will be randomly assigned to one of two groups. One group will receive usual care, which includes education about safe swallowing and written instructions on appropriate food textures. The other group will receive the same usual care plus access to the AI-enabled mobile app for 16 weeks. Participants will continue their daily eating routines at home.\n\nThe main question this study is trying to answer is: Does using the AI-enabled mobile app improve how often people eat foods that match their recommended safe texture level compared with usual care alone?\n\nThe study will also examine whether the app helps reduce swallowing-related problems (such as choking), improves quality of life, and supports better overall eating ability. In addition, the study will evaluate how easy the app is to use and whether it places any burden on users.\n\nHypothesis: The researchers hypothesize that participants who use the AI-enabled app, in addition to usual care, will more consistently follow recommended food texture guidelines and experience safer eating compared with those who receive usual care alone.",[170,28],"Deglutition Disorders",[28,172,173,174,175,176,177,178,179,180,181],"Deglutition disorders","Swallowing disorders","Texture modified diet","Food texture assessment","Artificial intelligence in health care","Clinical decision support systems","Digital health intervention","Older adults","Aging population","Mobile health applications","2026-06-12",{"date":184,"type":36},"2026-06-17",{"date":186,"type":22},"2028-01",{"date":188,"type":22},"2030-12",{"name":190,"class":85},"KAM Chi Shan Anna",{"id":192,"slug":193,"hasResults":12,"nctId":194,"briefTitle":195,"officialTitle":196,"acronym":4,"eligibilityCriteria":197,"healthyVolunteers":65,"sex":17,"minAge":18,"maxAge":66,"enrollmentInfo":198,"targetDuration":4,"studyType":23,"phases":200,"briefSummary":201,"conditions":202,"keywords":4,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":182,"lastUpdatePostDateStruct":208,"startDateStruct":209,"completionDateStruct":211,"leadSponsor":213,"locationsCount":86},"100560656","usefulness-and-feasibility-of-ultrasound-in-office-laryngology-procedures-100560656","NCT06579989","Usefulness and Feasibility of Ultrasound in Office Laryngology Procedures","Usefulness and Feasibility of Ultrasound in Office Laryngology Procedures: A Pilot Study","Inclusion Criteria:\n\n* US-Guided Injection for Neurogenic Cough:\n\n  1. Age over 18 years\n  2. Recommended to undergo superior laryngeal nerve block\n* US-Assessment of Superior Laryngeal Nerve Anatomy\n\n  1. Age over 18 years\n  2. No cough complaints\n* US-Assessment of Injectate Volume:\n\n  1. Documentation of unilateral vocal fold paresis\u002Fparalysis or atrophy\n  2. Age over 18 years\n  3. Recommended to undergo injection laryngoplasty\n* US-Assessment of Swallow:\n\n  1. Age over 18 years\n  2. Presents with swallowing complaints\n* US-Assessment of Normal Swallow:\n\n  1. Age over 18 years\n  2. Presents without swallowing complaints\n* US-Assessment of Voice:\n\n  1. Age over 18 years\n  2. Undergoing evaluation of voice problems\n\nExclusion Criteria:\n\n1. Age under 18 years and over 99 years\n2. Open neck wound including tracheostomy",{"count":199,"type":22},200,[25],"Investigators will assess the usefulness of using ultrasound in office procedures for laryngology interventions. Participants who qualify will be adults who are undergoing superior laryngeal nerve block, injection laryngoplasty, swallowing evaluation, voice evaluation and voice therapy.",[203,204,205,206,28,207],"Cough","Vocal Cord Atrophy","Vocal Cord Paresis","Vocal Cord Paralysis","Dysphonia",{"date":148,"type":36},{"date":210,"type":22},"2027-01",{"date":212,"type":22},"2030-01",{"name":214,"class":85},"Weill Medical College of Cornell University",{"id":216,"slug":217,"hasResults":12,"nctId":218,"briefTitle":219,"officialTitle":220,"acronym":4,"eligibilityCriteria":221,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":222,"targetDuration":4,"studyType":23,"phases":224,"briefSummary":225,"conditions":226,"keywords":228,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":232,"lastUpdatePostDateStruct":233,"startDateStruct":235,"completionDateStruct":237,"leadSponsor":239,"locationsCount":86},"100638966","biomechanical-effects-of-emst-on-swallowing-function-in-parkinsons-disease-100638966","NCT07606547","Biomechanical Effects of EMST® on Swallowing Function in Parkinson's Disease","Biomechanical Effects of Expiratory Muscle Strength Training (EMST®) on Swallowing Function in Parkinson's Disease - a Prospective High-resolution Manometry Study","Inclusion Criteria:\n\n* diagnosis of Parkinson's disease,\n* PD-related dysphagia as objectively diagnosed with FEES\n\nExclusion Criteria:\n\n* severe dementia, not able to give consent\n* dysphagia related to other diagnoses",{"count":223,"type":22},30,[25],"The aim of this non-randomized intervention study is to investigate the detailed effects of a structured four-week EMST® training program on the biomechanics of swallowing function in dysphagic Parkinson's patients. A combination of fiberoptic endoscopic evaluation of swallowing (FEES) and pharyngeal high-resolution manometry (HRM) will be employed to comprehensively evaluate the neuromuscular changes in swallowing.",[227,28],"Parkinson's Disease (PD)",[28,229,230,231],"Expiratory muscle strength training","Parkinson's Disease","High-resolution pharyngeal manometry","2026-06-01",{"date":234,"type":36},"2026-06-03",{"date":236,"type":22},"2026-06",{"date":238,"type":22},"2028-05",{"name":240,"class":85},"University Hospital Muenster",{"id":242,"slug":243,"hasResults":12,"nctId":244,"briefTitle":245,"officialTitle":246,"acronym":4,"eligibilityCriteria":247,"healthyVolunteers":12,"sex":17,"minAge":19,"maxAge":248,"enrollmentInfo":249,"targetDuration":4,"studyType":23,"phases":251,"briefSummary":252,"conditions":253,"keywords":255,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":232,"lastUpdatePostDateStruct":262,"startDateStruct":263,"completionDateStruct":265,"leadSponsor":267,"locationsCount":86},"100637459","effects-of-ctar-and-a-swallowing-pressure-ball-in-older-stroke-adults-100637459","NCT07620210","Effects of CTAR and a Swallowing Pressure Ball in Older Stroke Adults","Effectiveness of Combining Chin Tuck Against Resistance Swallowing Training and an Innovative Swallowing Pressure Measurement Ball on the Swallowing Function and Quality of Life in Home-Based Older Adults With Stroke","Inclusion Criteria:\n\n* Age between 65 and 90 years.\n* Diagnosed with ischemic or hemorrhagic stroke more than 6 months prior to enrollment.\n* Receiving home care services from participating home care agencies.\n* Able to follow instructions and participate in swallowing training.\n* MMSE score ≥24, or adjusted according to education level.\n* Passed the second stage of the 3-step swallowing screening test.\n* Presence of post-stroke dysphagia symptoms.\n\nExclusion Criteria:\n\n* History of head and neck cancer or head and neck radiotherapy.\n* History of cervical spine surgery or tracheostomy.\n* Severe neurological or neuromuscular diseases affecting swallowing function.\n* Severe unstable medical conditions.\n* Current use of medications significantly affecting swallowing function or muscle tone.\n* Unable to complete the intervention or follow-up assessments.\n* Receiving tube feeding without oral intake ability.","90 Years",{"count":250,"type":22},132,[25],"This study aims to investigate the effectiveness of resistance swallowing rehabilitation using Chin Tuck Against Resistance (CTAR) exercises combined with an innovative swallowing pressure ball in improving swallowing function and swallowing-related quality of life among home-based older stroke patients with dysphagia.\n\nParticipants will receive a 12-week swallowing rehabilitation program conducted in the home-care setting. Outcome measures include swallowing function assessments, swallowing-related quality of life, and rehabilitation adherence. The study is designed as a randomized controlled trial to explore the feasibility and clinical benefits of resistance-based swallowing rehabilitation in community and home-care environments.",[144,28,254],"Post-Stroke Dysphagia",[256,257,258,259,260,261],"CTAR","Swallowing Rehabilitation","Swallowing Pressure Ball","Home Care","Older Adults","Stroke Rehabilitation",{"date":234,"type":36},{"date":264,"type":36},"2026-03-18",{"date":266,"type":22},"2027-02-28",{"name":268,"class":85},"Chimei Medical Center",{"id":270,"slug":271,"hasResults":12,"nctId":272,"briefTitle":273,"officialTitle":273,"acronym":274,"eligibilityCriteria":275,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":276,"targetDuration":4,"studyType":23,"phases":278,"briefSummary":279,"conditions":280,"keywords":282,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":232,"lastUpdatePostDateStruct":290,"startDateStruct":291,"completionDateStruct":293,"leadSponsor":295,"locationsCount":86},"100530898","feasibility-of-early-swallowing-and-speech-intervention-for-head-and-neck-cancer-patients-treated-surgically-100530898","NCT06192771","Feasibility of Early Swallowing and Speech Intervention for Head and Neck Cancer Patients Treated SURGically","ESSI-SURG","Inclusion Criteria:\n\n* Newly diagnosed patients with at least T2 stage tongue SCC who are planned for partial glossectomy and free flap reconstruction and are anticipated to achieve a post-operative independent oral intake.\n* Proficient in spoken and written English\n\nExclusion Criteria:\n\n* Patients who are planned for total glossectomy",{"count":277,"type":22},40,[25],"Oral cavity cancer (OCC) is one of the most common cancers worldwide, with tongue cancer being one of the most common subtypes. Patients with oral cancers can experience painful swallowing, swallowing difficulty (dysphagia), and associated weight loss long after surgery. Not only is dysphagia an independent predictor of quality of life (QoL) in cancer survivorship, it can also have a devastating impact on the health of patients resulting from complications such as pneumonia, malnutrition and feeding tube dependence. Emerging evidence suggests that patients undergoing surgery benefit from engaging with speech-language pathologists (SLPs) before problems arise, to learn swallow strategies that may become useful in their rehabilitation. This in turn has the potential to reduce complications and minimize the length of feeding tube dependency.\n\nThis study will assess the feasibility of conducting a prospective clinical trial that would evaluate the effects on patient health, function and overall benefit of early and systematic SLP speech and swallowing intervention for head and neck cancer patients planned for curative surgical treatment. We will also assess long-term changes in select clinical and patient-reported outcomes comparing their status before, and one month after, treatment.",[28,281],"Head and Neck Cancer",[283,284,285,286,287,288,289],"dysphagia","head and neck cancer","speech language pathology","surgery","speech","early intervention","medical outcomes",{"date":234,"type":36},{"date":292,"type":36},"2023-12-01",{"date":294,"type":22},"2026-12-31",{"name":296,"class":85},"University Health Network, Toronto",{"id":298,"slug":299,"hasResults":12,"nctId":300,"briefTitle":301,"officialTitle":302,"acronym":303,"eligibilityCriteria":304,"healthyVolunteers":65,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":305,"targetDuration":4,"studyType":307,"phases":4,"briefSummary":308,"conditions":309,"keywords":312,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":317,"lastUpdatePostDateStruct":318,"startDateStruct":320,"completionDateStruct":322,"leadSponsor":324,"locationsCount":86},"100639039","ddk-acoustic-analysis-and-swallowing-indicators-100639039","NCT07626749","DDK Acoustic Analysis and Swallowing Indicators","Acoustic Analysis of Performance in Diadochokinetic (DDK) Tasks and Swallowing Function Indicators Among Adults Across Different Age Groups","AAP-DDK","Inclusion Criteria:\n\n* 1.Community-dwelling adults aged 18 years or older, with no upper age limit.\n* 2.Ability to communicate in Mandarin or Taiwanese and understand the study procedures.\n* 3.Willingness to provide written informed consent.\n* 4 .Ability to complete the DDK tasks and RSST.\n\nExclusion Criteria:\n\n* 1.Presence of acute respiratory infection, upper respiratory inflammation, or other acute conditions that may significantly affect speech or swallowing.\n* 2.Impaired consciousness, significant cognitive deficits, or inability to understand the study procedures.\n* 3.Recent surgery or radiotherapy involving the oral cavity or pharynx that affects speech or swallowing.\n* 4.Severe hearing impairment that prevents understanding of instructions.\n* 5.Any other condition deemed unsuitable for participation by the investigators.",{"count":306,"type":22},720,"OBSERVATIONAL","This study examines whether simple speech tasks and a swallowing screening test can help identify swallowing risk in adults of different ages. Participants will complete basic questions, a swallowing self-assessment, a saliva swallowing test, and short voice recordings of rapid syllables. The study is non-invasive, takes about 75 minutes, and may help develop an easy, low-cost screening tool for early swallowing problems.",[310,311,28],"Swallowing Function","Swallowing Risk",[28,310,313,314,315,316,260],"diadochokinetic","Acoustic Analysis","Repetitive Saliva Swallowing Test","EAT-10","2026-05-29",{"date":319,"type":36},"2026-06-04",{"date":321,"type":22},"2026-06-15",{"date":323,"type":22},"2030-04-09",{"name":325,"class":85},"Kaohsiung Medical University",{"id":327,"slug":328,"hasResults":12,"nctId":329,"briefTitle":330,"officialTitle":331,"acronym":332,"eligibilityCriteria":333,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":334,"enrollmentInfo":335,"targetDuration":4,"studyType":23,"phases":337,"briefSummary":338,"conditions":339,"keywords":342,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":350,"lastUpdatePostDateStruct":351,"startDateStruct":352,"completionDateStruct":354,"leadSponsor":356,"locationsCount":44},"100637338","maximizing-quality-of-life-after-cancer-through-rehabilitation-100637338","NCT07622407","Maximizing Quality of Life After Cancer Through Rehabilitation","A Transdisciplinary Interventions to MaximizE QuaLitY of Life After Cancer Through REHABilitation (TIMELY REHAB)","TIMELY REHAB","Inclusion Criteria:\n\nParticipants must be:\n\n* diagnosed with head and neck malignancy within the past 60 days;\n* prescribed a treatment plan at participating site that includes at least 1 dose of a cisplatin-based chemotherapy, or at least one dose of radiotherapy and\u002For surgery;\n* prescribed Intensive Dysphagia Therapy (IDT) at the participating site;\n* sufficient fluency in written English to be able to complete the study patient reported outcome questionnaires.\n\nExclusion Criteria:\n\nParticipants will be excluded is they have:\n\n* distant metastasis at enrollment;\n* diagnosis of second primary non-head and neck cancer in the thorax or the central nervous system at enrollment;\n* prior or planned total laryngectomy;\n* prior or planned cochlear implant;\n* head and neck radiotherapy for thyroid or cutaneous\u002Fskin primary tumors, regardless of neck fields;\n* cognitively or physically unable to participate (patient, physician or nurse report patient is incapable of participating), medical records indicate that participant exhibits aggressive behavior, participant has documented dementia, Alzheimer's disease, or severe psychosocial disorder, or notes indicate an individual is not legally capable of providing informed consent (participant has a legal guardian);\n* moderate\u002Fsevere dysphagia at enrollment per baseline videofluoroscopy DIGEST grade \\>=2;\n* severe\u002Fprofound hearing loss at enrollment per baseline audiogram;\n* exhibits Meniere's disease or retrocochlear disorder based on baseline hearing test results, patient report or notes in electronic medical records;\n* exhibits active or recent history of middle ear disorder based on otoscopy, tympanometry, baseline hearing test results, patient report, or medical record documentation;\n* unwilling to participate.","89 Years",{"count":336,"type":22},74,[25],"Treatment for head and neck cancer (HNC) often includes cisplatin chemotherapy and radiation. This treatment causes hearing loss and trouble swallowing in 70% of patients. If untreated, these symptoms increase stress and lower quality of life for survivors. Veterans with HNC usually get help for swallowing. However, damage to the hearing and balance systems-known as ototoxicity-is often missed or only addressed when it becomes very severe. To fill this gap, the investigators plan a clinical trial at two VA sites. The investigators compare the usual swallowing therapy alone to a new, more comprehensive program. This new program includes:\n\n1. the standard swallowing therapy,\n2. proactive management to protect hearing and balance or manage problems that can't be prevented, and\n3. other rehabilitation services based on a tele-oncology nurse's assessment. The hearing and balance intervention features quick screening tests and validated questionnaires to identify early signs of damage. These are given during cancer or radiation treatment visits to maximize convenience for the patient. Audiologists review these results remotely using tele-health technology. The investigators will also use new tools to predict and spot hearing problems that are personalized for each patient. The audiologist works closely with the patient and the care team to arrange further help if needed.\n\nThe tele-oncology nurse checks for other rehabilitation needs using a screening tool validated in Veterans, shares this information with the team, and advises patients about recommended care.\n\nThe investigators expect the results to show that managing hearing loss with swallowing therapy while improving care coordination for rehabilitation reduces survivors' stress and improves well-being compared to swallowing therapy alone.",[281,340,341,28],"Hearing Loss","Tinnitus",[343,344,345,346,281,347,28,348,349,341],"Audiology","Chemotherapy","Cisplatin","Drug-related side effects and adverse reactions","Ototoxicity","Professional practice gaps","Sensorineural hearing loss","2026-05-27",{"date":234,"type":36},{"date":353,"type":22},"2027-03-01",{"date":355,"type":22},"2030-06-30",{"name":357,"class":358},"VA Office of Research and Development","FED",{"id":360,"slug":361,"hasResults":12,"nctId":362,"briefTitle":363,"officialTitle":363,"acronym":4,"eligibilityCriteria":364,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":248,"enrollmentInfo":365,"targetDuration":4,"studyType":23,"phases":367,"briefSummary":368,"conditions":369,"keywords":4,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":372,"lastUpdatePostDateStruct":373,"startDateStruct":375,"completionDateStruct":376,"leadSponsor":378,"locationsCount":4},"100638430","transcutaneous-superior-laryngeal-nerve-stimulation-to-upregulate-swallowing-frequency-and-urge-to-swallow-in-patients-living-with-als-100638430","NCT07606235","Transcutaneous Superior Laryngeal Nerve Stimulation to Upregulate Swallowing Frequency and Urge to Swallow in Patients Living With ALS","Inclusion Criteria:\n\n* Confirmed diagnosis of ALS (El-Escorial Criteria)\n* ALS FRS Bulbar Subscore of ≤ 10 and ≥ 3.\n* Functional Oral Intake scale score ≥ 2\n\nExclusion Criteria:\n\n* A diagnosis of significant cognitive impairment or frontotemporal dementia per the treating neurologist or neuropsychologist,\n* Current nasogastric tube placement\n* Current head and neck carcinoma\n* Pacemaker or implanted defibrillator or history of diagnosed arrhythmia, bradycardia, or repeated attacks of hypotension,\n* Implanted vagal nerve stimulator\n* Current pregnancy\n* History of epilepsy\n* Infected, broken or inflamed skin on the neck, or impaired sensation at the site of sEMG or TENS placement\n* Living greater than 50 miles from the NSU clinic round trip\n* Any clinical reason that this stimulation may not be a suitable treatment according to the principal investigator.",{"count":366,"type":22},5,[25],"Prospective, single-arm pilot study evaluating transcutaneous electrical nerve stimulation of the superior laryngeal nerve (TENS-SLN) in individuals with ALS.\n\nUp to 5 participants with confirmed ALS and bulbar involvement will be enrolled.\n\nPrimary outcomes: swallowing frequency and perceived urge to swallow. Participants complete a baseline visit, followed by two supervised treatment sessions within one week, and a final post-treatment evaluation.\n\nOptional visits (up to 2) may be used to individualize stimulation parameters prior to treatment.\n\nSwallowing function will be assessed using physiological monitoring, fiberoptic endoscopy, and videofluoroscopic swallow study (VFSS).\n\nTENS-SLN is a non-invasive neuromodulation approach targeting sensory pathways to facilitate swallowing without inducing muscle contraction.\n\nThis pilot study is designed to assess feasibility, safety, and preliminary effect sizes to inform future randomized trials, and is not powered to determine efficacy.",[370,28,371],"Amyotrophic Lateral Sclerosis (ALS)","Dystussia","2026-05-18",{"date":374,"type":36},"2026-05-26",{"date":236,"type":22},{"date":377,"type":22},"2026-12",{"name":379,"class":85},"Nova Southeastern University",{"id":381,"slug":382,"hasResults":12,"nctId":383,"briefTitle":384,"officialTitle":385,"acronym":4,"eligibilityCriteria":386,"healthyVolunteers":65,"sex":17,"minAge":164,"maxAge":4,"enrollmentInfo":387,"targetDuration":4,"studyType":307,"phases":4,"briefSummary":389,"conditions":390,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":394,"lastUpdatePostDateStruct":395,"startDateStruct":397,"completionDateStruct":399,"leadSponsor":401,"locationsCount":86},"100568198","swallowing-impairments-in-adults-with-and-without-alzheimers-disease-100568198","NCT06678100","Swallowing Impairments in Adults With and Without Alzheimer's Disease","Prevalence and Care Partner Burden of Individuals With Alzheimer's Disease","Inclusion criteria for AD cohort:\n\n1. adult ≥60 years old\n2. diagnosis of AD by a neurologist (confirmed with imaging, spinal tap, behavioral testing)\n3. no prior history of other neurological diseases (aside from stroke which has resolved with no current symptoms)\n4. no prior history of respiratory diseases\n5. no prior history of head and neck surgery\u002Fhead and neck cancer\u002Fradiation to head and neck region\n6. consuming some form of oral intake\n7. able to follow basic directions\n8. able\u002Fwilling to provide consent\u002Fassent.\n\nExclusion Criteria for AD Cohort:\n\n1. individual \\\u003C60 years old\n2. Diagnosis of another type of dementia\n3. History of neurological\u002Frespiratory diseases\n4. History of head and neck surgery\u002Fhead and neck cancer\u002Fradiation to head and neck region\n5. not consuming any oral intake\n6. Unable to follow basic directions\n7. Unable to provide consent based on the University of California, San Diego Brief Assessment of Capacity to Consent (UBACC), score \\\u003C15 OR provide assent and a legal guardian\u002Fhealth care decision maker provides consent.\n\nInclusion criteria for care partners of individuals with AD will be:\n\n1. care partner of an individual with AD\n2. willing to complete questionnaires\u002Fparticipate in an interview.\n\nExclusion Criteria for Caregivers of Individuals with AD:\n\n1. not the primary caregiver of an individual with AD\n2. unwilling to complete questionnaires\u002Fsemi-structured interview\n\nInclusion criteria for community-dwelling adults will be:\n\n1. adult ≥60 years old\n2. no prior history of neurological diseases (aside from stroke which has resolved with no current symptoms)\n3. no prior history of respiratory diseases\n\n3\\) no prior history of head and neck surgery\u002Fhead and neck cancer\u002Fradiation to head and neck region 4) no prior history of swallowing difficulties based on participant report. 5) Score ≥25th percentile based on sex\u002Fage\u002Feducation\u002Frace on the Montreal Cognitive Assessment (MOCA)\n\nExclusion Criteria for Healthy Cohort:\n\n1. individual \\\u003C60 years old\n2. history of neurological disease\n3. history of respiratory disease\n4. history of head and neck surgery\u002Fhead and neck cancer\u002Fradiation to head and neck region\n5. history of swallowing difficulties\n6. Score \\\u003C25th percentile based on sex\u002Fage\u002Feducation\u002Frace on the Montreal Cognitive Assessment (MOCA)",{"count":388,"type":22},240,"This research study is investigating whether people with Alzheimer's disease (AD) experience more changes to swallowing than their healthy age-matched peers. The prevalence of swallowing impairments in moderate-severe AD is high (85-93%), yet little is known about how swallow function evolves throughout the disease course in people with AD. The overall objective of this study is to evaluate swallowing function in adults with and without Alzheimer's disease. The investigator will also be involving the primary caregivers of individuals with Alzheimer's that are enrolled in the study to better understand the impact of swallowing impairments on the primary caregivers of those with Alzheimer's Disease.\n\nHealthy adults and individuals with Alzheimer's disease will:\n\n* undergo tests of cough and swallow function\n* undergo tests of grip and tongue strength\n* complete questionnaires\n\nCaregivers of individuals with Alzheimer's disease will also complete questionnaires.",[391,392,393,28],"Alzheimer Disease","Caregiver Burden","Healthy Aging","2026-05-06",{"date":396,"type":36},"2026-05-08",{"date":398,"type":36},"2025-04-21",{"date":400,"type":22},"2028-02",{"name":402,"class":85},"Vanderbilt University Medical Center",{"id":404,"slug":405,"hasResults":12,"nctId":406,"briefTitle":407,"officialTitle":408,"acronym":409,"eligibilityCriteria":410,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":411,"targetDuration":4,"studyType":23,"phases":413,"briefSummary":415,"conditions":416,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":418,"lastUpdatePostDateStruct":419,"startDateStruct":420,"completionDateStruct":422,"leadSponsor":424,"locationsCount":86},"100567617","phase-2-corticosteroids-for-post-extubation-dysphagia-100567617","NCT06670521","Corticosteroids for Post-Extubation Dysphagia","Randomized Trial of Corticosteroids for Post-Extubation Aspiration","COPED","Inclusion Criteria:\n\n* Participant enrolled in primary study COMIRB #21-3873\u002F NCT # 05108896\n* Laryngeal edema identified on participants primary study Fiberoptic Endoscopic Evaluation of Swallowing (FEES) as defined as a revised Patterson edema score greater than zero\n* Admission to an ICU during their hospitalization\n* Mechanical ventilation with an endotracheal tube for greater than 48 hours.\n* Extubation except for compassionate extubation or transition to end-of-life care.\n\nExclusion Criteria:\n\n* Patient or provider refusal\n* Contraindication or corticosteroids defined as an allergic reaction (extremely rate) or taking other immunosuppressive medications.\n* Chronic treatment with corticosteroids (\\>= 40 mg Prednisone\u002Fday, \\>=32 Methylprednisolone\u002Fday)\n* Contraindication to enteral\u002Foral nutrition administration.\n* Pre-existing history of dysphagia or aspiration.\n* Pre-existing or acute primary central or peripheral neuromuscular disorder.\n* Presence of a chronic tracheostomy (present prior to ICU admission).\n* Pre-existing head and neck cancer or surgery.\n* Coagulopathy resulting in uncontrolled nasal or pharyngeal bleeding.\n* Delirium as assessed by CAM-ICU\n* Inability to obtain informed consent from patient or an appropriate surrogate.\n* Age \\\u003C18 years.",{"count":412,"type":22},80,[414],"PHASE2","This is a placebo-controlled, double-blind randomized trial of a short course of intravenous corticosteroids for Acute Respiratory Failure Survivors with Fiberoptic Endoscopic Evaluation of Swallowing (FEES) documented laryngeal edema. Study was leveraged using the existing R01 grant infrastructure COMIRB # 21-3873, study design, and research methods. Patients for the study proposed will have already been enrolled in the R01 longitudinal cohort study. The sites to perform this study include Colorado, BU, Yale, Tufts, and Stanford. Those R01-enrolled patients with laryngeal edema on their initial FEES examination: defined as the revised Patterson edema score greater than zero, will be approached for enrollment.",[28,417],"Laryngeal Edema","2026-05-04",{"date":394,"type":36},{"date":421,"type":36},"2024-12-02",{"date":423,"type":22},"2027-05-31",{"name":425,"class":85},"University of Colorado, Denver",{"id":427,"slug":428,"hasResults":12,"nctId":429,"briefTitle":430,"officialTitle":431,"acronym":432,"eligibilityCriteria":433,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":434,"targetDuration":4,"studyType":23,"phases":436,"briefSummary":437,"conditions":438,"keywords":439,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":418,"lastUpdatePostDateStruct":443,"startDateStruct":444,"completionDateStruct":446,"leadSponsor":448,"locationsCount":86},"100282760","dysphagia-evaluation-after-stroke--effect-oral-neuromuscular-training-on-swallowing-dysfunction-100282760","NCT02960737","Dysphagia Evaluation After Stroke- Effect Oral Neuromuscular Training on Swallowing Dysfunction","Dysphagia Evaluation After Stroke - a Randomized Controlled Trial of Oral Neuromuscular Training on Swallowing Dysfunction (DESIRE)","DESIRE","Inclusion Criteria:\n\n* Persistent dysphagia 12(±3) weeks after STROKE.\n\nExclusion Criteria:\n\n* Stroke patients with neurologic or psychiatric disorders or other diseases\u002Fconditions that can affect swallowing function.\n* Unable to collaborate due to other serious diseases and\u002For to affected general condition.",{"count":435,"type":22},60,[25],"The aim of this study is to investigate the effect of a specific rehabilitation program with an oral device used in stroke patients with persistent oral-and pharyngeal dysphagia.",[28,144],[28,144,440,441,442],"Intervention","Oral neuromuscular training","Randomized control trial",{"date":396,"type":36},{"date":445,"type":36},"2022-12-01",{"date":447,"type":22},"2029-03",{"name":449,"class":85},"Umeå University",{"id":451,"slug":452,"hasResults":12,"nctId":453,"briefTitle":454,"officialTitle":455,"acronym":4,"eligibilityCriteria":456,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":248,"enrollmentInfo":457,"targetDuration":4,"studyType":23,"phases":459,"briefSummary":460,"conditions":461,"keywords":463,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":471,"lastUpdatePostDateStruct":472,"startDateStruct":474,"completionDateStruct":476,"leadSponsor":478,"locationsCount":86},"100530698","respiratory-strength-training-in-heart-transplant-recipients-100530698","NCT06190171","Respiratory Strength Training in Heart Transplant Recipients","Impact of Preoperative Respiratory Strength Training on Postoperative Health for Heart Transplant Recipients","Inclusion Criteria:\n\n1. Adult (18-90 years old)\n2. Not pregnant\n3. Undergoing evaluation or actively waitlisted for heart transplantation at VUMC with a waitlist status of 1-6\n4. Have a computer, tablet or electronic device with a stable internet connection for telehealth sessions (outpatient)\n5. Be willing to undergo testing procedures and complete the exercise training program.\n\nExclusion Criteria:\n\n1. Individual \\\u003C18 years old, \\>90 years old\n2. Pregnant\n3. No access to a computer, tablet or electronic device with a stable internet connection for telehealth sessions\n4. Unwilling or unable to undergo testing procedures and complete the exercise training program.",{"count":458,"type":22},90,[25],"This research study is investigating whether completing breathing exercises before surgery helps heart transplant patients recover after surgery. Previous studies have shown that breathing exercises can improve breathing, cough, and swallow function in patients with other diseases\u002Fconditions. The current study will investigate the impact of a preoperative respiratory muscle strength training program on breathing and cough function, swallow function, patient-reported eating and swallowing fatigue, and health outcomes in individuals undergoing heart transplantation.\n\nParticipants will:\n\n* undergo tests of breathing, cough, and swallow function\n* complete questionnaires about the treatment, their swallow function\n* complete breathing exercises daily",[28,462],"Heart Transplant Recipients",[283,464,465,73,466,467,468,469,470],"deglutition","deglutition disorders","breathing","cough","swallowing disorders","heart transplant recipients","respiratory muscle strength training","2026-05-01",{"date":473,"type":36},"2026-05-07",{"date":475,"type":36},"2024-05-17",{"date":477,"type":22},"2027-03-31",{"name":402,"class":85},{"id":480,"slug":481,"hasResults":12,"nctId":482,"briefTitle":483,"officialTitle":484,"acronym":4,"eligibilityCriteria":485,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":486,"targetDuration":4,"studyType":23,"phases":488,"briefSummary":489,"conditions":490,"keywords":494,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":500,"lastUpdatePostDateStruct":501,"startDateStruct":503,"completionDateStruct":505,"leadSponsor":507,"locationsCount":86},"100613242","velopharyngeal-dysfunction-in-head--neck-cancer-patients-pilot-study-100613242","NCT07264036","Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study","Injectable Augmentation Outcomes in Post-Radiation Head and Neck Cancer Patients With Velopharyngeal Dysfunction","Inclusion Criteria:\n\nEnglish-speaking adults (≥18 years) History of head and neck cancer treated with surgical resection, chemoradiation, or both Presence of perceptual hypernasality on clinical assessment\n\nExclusion Criteria:\n\nPre-existing or suspected non-cancer-related causes of velopharyngeal dysfunction Contraindications to pharyngeal wall augmentation Requirement for more intensive active cancer surveillance Planned future surgical or medical treatments to the pharynx that would interfere with participation",{"count":487,"type":22},20,[25],"Some head and neck cancer survivors develop velopharyngeal dysfunction (VPD), a problem with closure between the soft palate and throat that can cause nasal-sounding speech, food or liquid leaking into the nose, difficulty swallowing, and reduced quality of life. This study aims to better understand VPD in this population and to evaluate whether pharyngeal wall augmentation (plumping up the back wall of the throat) can improve speech and swallowing.\n\nParticipants will undergo a multidisciplinary assessment including physical examination, flexible nasolaryngoscopy, speech recording and acoustic analysis, nasometry, clinical swallowing evaluation, and fiberoptic endoscopic evaluation of swallowing (FEES).\n\nAim 1: Determine the prevalence, severity, and functional impact of VPD in head and neck cancer survivors.\n\nAim 2: Assess the feasibility and usefulness of advanced diagnostic tools for VPD.\n\nThe investigators hypothesize that high nasalance scores (\\>1 SD above normal) will accurately predict VPD with at least 75% positive predictive value and will correlate with worse communication-related quality of life (CPIB).\n\nThe investigators also hypothesize that participants with VPD will have more pharyngeal residue or nasal regurgitation on FEES, and that these findings will be associated with lower swallowing-related quality of life (SWAL-QOL).\n\nAim 3: Evaluate the effectiveness of pharyngeal wall augmentation injections for improving speech intelligibility and swallowing function.\n\nThe investigators expect that this treatment will lead to measurable changes in both objective assessments and patient-reported outcomes. The results will help improve diagnosis and management of VPD in head and neck cancer survivors.",[491,281,492,28,493],"Velopharyngeal Insufficiency","Survivorship","Speech Disorder",[495,496,497,498,284,499],"velopharyngeal dysfunction","hypernasal speech","pharyngeal wall augmentation","nasometry","survivorship","2026-04-27",{"date":502,"type":36},"2026-04-28",{"date":504,"type":36},"2026-03-24",{"date":506,"type":22},"2027-07-01",{"name":508,"class":85},"Vanessa Torrecillas",{"id":510,"slug":511,"hasResults":12,"nctId":512,"briefTitle":513,"officialTitle":514,"acronym":4,"eligibilityCriteria":515,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":516,"targetDuration":4,"studyType":23,"phases":518,"briefSummary":519,"conditions":520,"keywords":4,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":521,"lastUpdatePostDateStruct":522,"startDateStruct":523,"completionDateStruct":525,"leadSponsor":527,"locationsCount":4},"100636267","system-integrated-technology-enabled-model-of-care-to-improve-the-health-of-stroke-patients-with-dysphagia-100636267","NCT07563465","System-integrated Technology-enabled Model of Care to Improve the Health of Stroke Patients With Dysphagia","System-integrated Technology-enabled Model of Care to Improve the Health of Stroke Patients With Dysphagia: a Cluster-randomized Controlled Study","Inclusion Criteria:\n\n* discharged ischemic stroke survivors\n* disease duration ≤3 months\n* Dysphagia Outcome and Severity Scale grade ranging 1-5 levels.\n* stable vital signs, out of the acute phase, and not requiring long-term bed rest and monitoring.\n* reside locally for the next year.\n* basic communication ability and offering informed consent.\n* having and being able to use smart phones.\n* free from aspiration pneumonia or its symptoms\n\nExclusion Criteria:\n\n* expected lifespan ≤1 year\n* other severe systemic diseases.\n* participating in other clinical trials.\n* severe cognitive or psychiatric disorders, or severe aphasia.\n* pregnant or lactating women.",{"count":517,"type":22},600,[25],"The goal of this clinical trial is to explore the effects of the system-integrated technology-enabled model of care in ischemic stroke patients with dysphagia. The main question it aims to answer is: Can one-year system-integrated technology-enabled model of care improve the incidence of aspiration pneumonia, swallowing function, nutritional status, self-care ability, and quality of life among post-discharge ischemic stroke patients with dysphagia.\n\nResearchers will compare system-integrated technology-enabled model group and control group to see if there are significant intergroup differences in the incidence of aspiration pneumonia, swallowing function, nutritional status, self-care ability, and quality of life.\n\nParticipants will be divided into the system-integrated technology-enabled model group and the control group. Participants in the system-integrated technology-enabled model group will receive support and follow-up services for dysphagia management, as well as physician-patient communication, with the assistance of mobile phones for one year. Participants in the control group will receive routine management.",[28],"2026-04-25",{"date":418,"type":36},{"date":524,"type":22},"2026-05",{"date":526,"type":22},"2027-11",{"name":528,"class":85},"Zeng Xi",{"id":530,"slug":531,"hasResults":12,"nctId":532,"briefTitle":533,"officialTitle":534,"acronym":4,"eligibilityCriteria":535,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":536,"targetDuration":4,"studyType":23,"phases":538,"briefSummary":539,"conditions":540,"keywords":541,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":543,"lastUpdatePostDateStruct":544,"startDateStruct":546,"completionDateStruct":548,"leadSponsor":550,"locationsCount":86},"100485655","non-standardized-vs-standardized-screening-for-dysphagia-100485655","NCT05603897","Non-standardized vs. Standardized Screening for Dysphagia","Utility of Non-standardized Clinical Swallow Evaluation vs. Standardized Swallow Evaluation to Identify the Presence of Dysphagia and Risk for Aspiration in Patients Post-ischemic Stroke in Acute Inpatient Rehabilitation","Inclusion Criteria:\n\n* Adults ≥ 18 years old\n* Patients admitted to Lynn Rehabilitation Center with an admitting diagnosis consistent with acute ischemic stroke within the past 1 month\n* Patients able to provide informed, written consent. If patients are not cognitively able to give informed consent, then consent will be obtained from patient proxy in person or over the phone\n* Able to read and comprehend verbal instruction in English and\u002For Spanish\n\nExclusion Criteria:\n\n* Adults \\> 80 years old\n* Pregnant women\n* Prisoners\n* Those with a prior history of dysphagia\n* Those with any diagnoses that include acute intracranial hemorrhage, subdural hematoma, subarachnoid hemorrhage, traumatic brain injury",{"count":537,"type":22},50,[25],"The purpose of this study is to compare two different screening tests for detecting dysphagia (difficulty swallowing) as well as the risk for aspiration (silent swallowing of liquids\u002Fsolids into the lungs) in patients after an ischemic stroke (when a blood clot blocks or narrows an artery leading to the brain).",[28],[542],"difficulty swallowing","2026-04-23",{"date":545,"type":36},"2026-04-29",{"date":547,"type":36},"2024-04-05",{"date":549,"type":22},"2026-11-30",{"name":551,"class":85},"University of Miami",{"id":553,"slug":554,"hasResults":12,"nctId":555,"briefTitle":556,"officialTitle":556,"acronym":4,"eligibilityCriteria":557,"healthyVolunteers":65,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":558,"targetDuration":4,"studyType":23,"phases":560,"briefSummary":561,"conditions":562,"keywords":564,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":569,"lastUpdatePostDateStruct":570,"startDateStruct":571,"completionDateStruct":573,"leadSponsor":575,"locationsCount":86},"100562119","swallowing-difficulties-in-people-over-60-years-prevalence-degree-of-difficulty-and-intervention-100562119","NCT06599021","Swallowing Difficulties in People Over 60 Years: Prevalence, Degree of Difficulty and Intervention","Inclusion Criteria:\n\n* Participation in SCAPIS2\n* Swallowing dysfunction according to timed water swallow test or\n* Swallowing dysfunction according to self-report\n\nExclusion Criteria:\n\n* Severely impaired intellectual abilities.\n* Inability to consent to inclusion in the study.\n* Inability to answer written questionnaires in Swedish\n\nInclusion of non-dysphagia control cohort: No signs of aspiration, slow swallowing (\\<10 ml\u002Fsec) or self-rated difficulties with eating and swallowing in sub-study SCAPIS2",{"count":559,"type":22},99,[25],"Participants included in SCAPIS2 (Swedish Cardio Pulmonary bioimage study) are screened regarding swallowing difficulty using a timed water swallow test. Participants who show signs of swallowing difficulty (dysphagia) are included in the present study, which encompasses s flexible endoscopic evaluation of swallowing function (FEES). Participants showing a moderate-severe dysphagia are randomized into one of three intervention groups: muscle strengthening training, skill-based swallowing training and a control group who will receive compensatory treatment. The study is expected to improve diagnostics and treatment of swallowing difficulties in an ageing population.",[28,440,563],"Ageing",[28,565,566,567,568],"Age-related dysphagia","Health-related quality of life","Dysphagia intervention","Dysphagia characteristics","2026-04-22",{"date":500,"type":36},{"date":572,"type":36},"2024-12-01",{"date":574,"type":22},"2028-04",{"name":576,"class":85},"Lisa Tuomi",{"id":578,"slug":579,"hasResults":12,"nctId":580,"briefTitle":581,"officialTitle":581,"acronym":582,"eligibilityCriteria":583,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":584,"enrollmentInfo":585,"targetDuration":586,"studyType":307,"phases":4,"briefSummary":587,"conditions":588,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":589,"lastUpdatePostDateStruct":590,"startDateStruct":592,"completionDateStruct":594,"leadSponsor":596,"locationsCount":86},"100635210","clinical-and-instrumental-assessment-tools-for-neurogenic-dysphagia-translation-and-validation-100635210","NCT07549724","Clinical and Instrumental Assessment Tools for Neurogenic Dysphagia: Translation and Validation","Val_Dysphagia","IInclusion Criteria:\n\nAdult patients (≥18 years) diagnosed with neurogenic dysphagia due to any neurological condition (e.g., stroke, Parkinson's disease, multiple sclerosis, traumatic brain injury) Able to understand and comply with study procedures Provide written informed consent (or legal representative consent if necessary) Stable medical and neurological condition at the time of assessment\n\nExclusion Criteria:\n\nActive respiratory infection or acute illness affecting swallowing at the time of assessment History of head and neck surgery or anatomical abnormalities preventing standardized assessment of swallowing or reflex cough Severe uncontrolled comorbidities (cardiac, pulmonary, or systemic) that make study participation unsafe","85 Years",{"count":96,"type":22},"1 Week","This study aims to translate and validate Italian versions of several clinical assessment tools for patients with neurogenic dysphagia. The instruments include:\n\nThe New Zealand Secretion Severity Scale, which evaluates secretion management; The Reflex Cough Test from the I\\&I cranial nerves assessment; The VASES scale used during fiberoptic endoscopic evaluation of swallowing; The Drooling Severity Scale, which measures saliva control.\n\nThe study will include approximately 100 patients with neurogenic dysphagia. The goal is to provide reliable, standardized tools in Italian to support clinicians in assessing swallowing and oral-motor function in patients with neurological disorders.",[28],"2026-04-17",{"date":591,"type":36},"2026-04-24",{"date":593,"type":36},"2025-03-09",{"date":595,"type":22},"2028-12-30",{"name":597,"class":85},"IRCCS San Camillo, Venezia, Italy",{"id":599,"slug":600,"hasResults":12,"nctId":601,"briefTitle":602,"officialTitle":603,"acronym":604,"eligibilityCriteria":605,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":606,"targetDuration":4,"studyType":23,"phases":608,"briefSummary":609,"conditions":610,"keywords":612,"overallStatus":76,"whyStopped":4,"lastUpdateSubmitDate":614,"lastUpdatePostDateStruct":615,"startDateStruct":617,"completionDateStruct":619,"leadSponsor":621,"locationsCount":4},"100633632","effectiveness-of-transcutaneous-nmes-as-an-adjunct-for-swallowing-disorders-in-tracheotomized-patients-100633632","NCT07529210","Effectiveness of Transcutaneous NMES as an Adjunct for Swallowing Disorders in Tracheotomized Patients","Evaluation of the Effectiveness of Transcutaneous Neuromuscular Electrical Stimulation as an Adjunct to Standard Treatment for Swallowing Disorders in Tracheotomized Patients Following Prolonged Mechanical Ventilation Weaning","SWALEC","Inclusion Criteria:\n\n* Hospitalized in intensive care units, post-ICU rehabilitation, or weaning and rehabilitation services;\n* Presence of a tracheostomy for more than 72 hours due to difficult mechanical ventilation weaning;\n* Diagnosis of swallowing disorders (swallowing fiberoscopy);\n* Patient aged at least 18 years at the time of inclusion;\n* Affiliated to a social security scheme or beneficiary of such a scheme;\n* Written, free and informed consent of the patient or their next of kin.\n\nExclusion Criteria:\n\n* Contra- indication to cervical NMES;\n* History of swallowing disorders;\n* Patient with a spinal cord injury above C5 level;\n* History of head and neck cancer;\n* Person under legal protection measures;\n* Patient under guardianship or conservatorship;\n* Known pregnancy;\n* Limitation of care.",{"count":607,"type":22},238,[25],"Dysphagia can reach a prevalence of up to 80% in intensive care patients. The implementation or prolonged presence of medical devices such as the intubation tube, tracheostomy, or nasogastric tube alters the physiology of swallowing and causes local injuries at several levels. Additionally, certain medical treatments impair swallowing physiology and the patient's alertness, further promoting the development of these disorders.\n\nManagement of dysphagia involves two main types of strategies: adaptive or compensatory maneuvers and rehabilitation techniques such as: performing praxis or swallowing exercises; physical stimulation (tactile or thermal); transcranial stimulation (electrical or magnetic); and finally, pharyngeal or transcutaneous electrical stimulation (NMES).\n\nPatients hospitalized in intensive care often present with altered levels of alertness, asynchronous ventilation and swallowing, and reduced motor capabilities, making it difficult to perform techniques like praxis, food trials, or resistance swallowing exercises. NMES does not require active patient cooperation or the permanent presence of the therapist during the stimulation session, thus increasing the intensity of dysphagia rehabilitation and the early implementation of treatment in these patients, complementing conventional rehabilitation. Muscle and sensory stimulation through the application of NMES can help increase the strength of the muscles involved in swallowing and improve sensory capabilities. However, its effects have not yet been evaluated in tracheostomized patients undergoing weaning from prolonged mechanical ventilation.",[28,611],"NeuroMuscular Electrical Stimulation",[613],"Deglutition","2026-04-09",{"date":616,"type":36},"2026-04-14",{"date":618,"type":22},"2026-03-26",{"date":620,"type":22},"2028-06-30",{"name":622,"class":85},"Hopital Forcilles",{"id":624,"slug":625,"hasResults":12,"nctId":626,"briefTitle":627,"officialTitle":628,"acronym":629,"eligibilityCriteria":630,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":631,"targetDuration":4,"studyType":307,"phases":4,"briefSummary":633,"conditions":634,"keywords":638,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":614,"lastUpdatePostDateStruct":650,"startDateStruct":651,"completionDateStruct":652,"leadSponsor":654,"locationsCount":86},"100632230","symptoms-and-quality-of-life-in-patients-with-heterotopic-gastric-mucosa-hgm-100632230","NCT07510984","Symptoms and Quality of Life in Patients With Heterotopic Gastric Mucosa (HGM)","Prevalence and Characterization of Dysphagia and Dyspepsia Symptoms and Assessment of Quality of Life in Heterotopic Gastric Mucosa (HGM)","SYM-HGM","Inclusion Criteria:\n\n* Planned upper gastrointestinal endoscopy (gastroscopy) for clinical reasons (any indication)\n* Age ≥ 18 years\n* Written informed consent\n* Ability to complete the study questionnaires prior to endoscopy\n\nExclusion Criteria:\n\n* Previously known heterotopic gastric mucosa (HGM)\n* Previously diagnosed dysphagia with prior therapeutic intervention (including pre-established diet modification, partial oral\u002Fenteral nutrition, steroid therapy, botulinum toxin injection, etc.)\n* Mechanical ventilation\n* Presence of a tracheostomy\n* Inadequate endoscopic assessability of the proximal esophagus, including:\n* General condition insufficient for careful endoscopic inspection (investigator's judgement)\n* Increased risk of aspiration\n* Inadequate visibility during the procedure (e.g., bleeding, food residue)\n* Complications preventing careful inspection of the proximal esophagus\n* History of surgery involving the pharynx or esophagus\n* Relevant severe neurological disorder (e.g., ALS, stroke)\n* Severe dementia\n* Severe depressive disorder\n* Lack of cooperation \u002F inability to comply with study procedures\n* Planned PEG placement\n* Emergency endoscopy",{"count":632,"type":22},721,"The goal of this observational study is to learn whether heterotopic gastric mucosa (HGM) in the upper esophagus is associated with swallowing difficulties (dysphagia) in adults undergoing a medically indicated gastroscopy. The main questions it aims to answer are:\n\n* Is the presence of HGM associated with dysphagia?\n* Is the presence of HGM associated with dyspepsia and reduced health-related quality of life? Among participants reporting dysphagia, what is the distribution of oropharyngeal versus esophageal dysphagia, and is this related to the presence of HGM? If there is a comparison group: Researchers will compare participants with endoscopically confirmed HGM to participants without HGM to determine whether dysphagia, dyspepsia symptoms, and quality-of-life measures differ between groups.\n\nParticipants will:\n\nComplete pseudonymised questionnaires about dysphagia, dyspepsia symptoms, and quality of life before the gastroscopy.\n\nUndergo the medically indicated gastroscopy as planned; the endoscopist will assess whether HGM is present based on the endoscopic appearance, and routine endoscopy findings will be documented.",[635,636,28,637],"Heterotopic Gastric Mucosa of the Proximal Esophagus","Gastric Inlet Patches","Dyspepsia",[639,640,641,642,643,644,316,645,646,647,648,649],"Cervical Esophagus","Proximal Esophagus","Upper Endoscopy","Oropharyngeal Dysphagia","Eophageal Dysphagia","Sidney Swallowing Questionnaire","MDADI","GSRS","QOLRAD","Narrow Band Imaging","Quality of Life",{"date":616,"type":36},{"date":504,"type":36},{"date":653,"type":22},"2027-07",{"name":655,"class":85},"Knappschaft Kliniken GmbH",{"id":657,"slug":658,"hasResults":12,"nctId":659,"briefTitle":660,"officialTitle":661,"acronym":4,"eligibilityCriteria":662,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":663,"targetDuration":4,"studyType":23,"phases":664,"briefSummary":665,"conditions":666,"keywords":670,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":674,"lastUpdatePostDateStruct":675,"startDateStruct":677,"completionDateStruct":679,"leadSponsor":681,"locationsCount":86},"100632764","chewing-gum-and-cold-gargle-on-post-bronchoscopy-symptoms-100632764","NCT07517926","Chewing Gum and Cold Gargle on Post-Bronchoscopy Symptoms","The Effect of Chewing Gum and Gargling With Cold Water on Post-Bronchoscopy Sore Throat, Dysphagia, and Patient Satisfaction: A Randomized Controlled Study","Inclusion Criteria:\n\n* • Being 18 years of age or older\n\n  * Having a scheduled diagnostic bronchoscopy\n  * Having normal speech and swallowing functions\n  * Being conscious and able to communicate\n  * Volunteering to participate in the study\n\nExclusion Criteria:\n\n* • Complications during bronchoscopy\n\n  * Gastroesophageal reflux\n  * Use of non-steroidal anti-inflammatory drugs\n  * Receiving steroid treatment within 1 week prior to the procedure\n  * Active infection or disease in the mouth or throat area\n  * History of allergy or intolerance to the procedure\n  * Previous anatomical or functional impediment to chewing gum or gargling",{"count":96,"type":22},[25],"This study aims to evaluate the effects of chewing gum and gargling with cold water on common post-bronchoscopy symptoms, such as sore throat and difficulty swallowing (dysphagia). Bronchoscopy is a procedure that can cause temporary throat discomfort. In this randomized controlled trial, patients will be divided into groups to receive either chewing gum, cold water gargle, or standard care. The researchers will then measure and compare patient satisfaction levels and the severity of throat symptoms to determine if these simple interventions can improve patient comfort after the procedure.",[667,28,668,669],"Sore Throat","Patient Satisfaction","Bronchoscopy",[669,667,28,671,672,673],"Chewing Gum","Cold Water Gargle","Nursing Care","2026-04-07",{"date":676,"type":36},"2026-04-13",{"date":678,"type":36},"2025-11-10",{"date":680,"type":22},"2026-05-11",{"name":682,"class":85},"Ankara University"]